Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC Consortium

Conclusions:
Both HE4 and CA125 are not reliable biomarkers for the diagnosis of BOT or for predicting the presence of invasive implants.

Source: Journal of Ovarian Research - May 7, 2014 Category: Cancer & Oncology Authors: Elena BraicuToon Van GorpMani NassirRolf RichterRadoslav ChekerovKhayal GasimliDirk TimmermanIgnace VergoteJalid Sehouli Source Type: research